Cowen analyst Eric Schmidt reiterated an Outperform rating and $146 price target on Celgene (NASDAQ: CELG) after the company hosted ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE